Gülhane Training and Research Hospital, formerly known as Gülhane Military Medical Academy, was founded by Abdülhamit II in 1898 in Istanbul as Gülhane Seririyat Hospital. It moved to Ankara in 1941.

During the past decade, Gulhane Military Medical Academy conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gulhane Military Medical Academy" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Saglik Bilimleri Universitesi Gulhane Tip Fakultesi" with 4 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Abbott Nutrition" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gulhane Military Medical Academy" #1 collaborator was "Private Gozde Hospital" with 2 trials as a collaborator, "Private Yenisehir Hospital" with 2 trials as a collaborator, "Saglik Bilimleri Universitesi Gulhane Tip Fakultesi" with 2 trials as a collaborator, "argenx" with 2 trials as a collaborator and "Abant Izzet Baysal University" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Gulhane Military Medical Academy" are "Coronary Artery Disease" (2 trials), "Coronary Artery Ectasia" (2 trials), "Multiple Myeloma" (2 trials), "Slow-Flow Phenomenon" (2 trials) and "Anxiety" (1 trials). Many other conditions were trialed in "Gulhane Military Medical Academy" in a lesser frequency.

Most popular intervention types in "Gulhane Military Medical Academy" are "Drug" (8 trials), "Biological" (2 trials), "Procedure" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Azacitidine" (2 trials), "Cusatuzumab" (2 trials), "Placebo" (2 trials) and "coronary angiography" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gulhane Military Medical Academy" are 15 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Gulhane Military Medical Academy". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Gulhane Military Medical Academy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gulhane Military Medical Academy, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".